Angioline is a Russian manufacturer of medical devices for interventional cardiology and surgery. The company was founded in 2007 in the TechnoPark Research Center of Akademgorodok, Novosibirsk, Russia. Angioline’s portfolio includes SINUS bare metal stents, CALIPSO drug eluting stents with bioresorbable polymer, guide wires, COLIBRIS coronary balloon catheters and accessories for endovascular diagnosis and treatment of heart and blood vessels diseases, surgical sutures. The Company has the following certificates: ISO 9001:2008, ISO 13485:2012. There were more than 100,000 implantations of Angioline coronary stents in 159 hospitals in 63 regions of Russia.